Tested Applications
| Positive WB detected in | HEK-293 cells, HeLa cells, NIH/3T3 cells, HepG2 cells |
| Positive IHC detected in | human stomach cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:8000 |
| Immunohistochemistry (IHC) | IHC : 1:400-1:1600 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
19902-1-AP targets GULP1 in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag13829 Product name: Recombinant human GULP1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-133 aa of BC001103 Sequence: MNRAFSRKKDKTWMHTPEALSKHFIPYNAKFLGSTEVEQPKGTEVVRDAVRKLKFARHIKKSEGQKIPKVELQISIYGVKILEPKTKEVQHNCQLHRISFCADDKTDKRIFTFICKDSESNKHLCYVFDSEKC Predict reactive species |
| Full Name | GULP, engulfment adaptor PTB domain containing 1 |
| Calculated Molecular Weight | 167 aa, 19 kDa |
| Observed Molecular Weight | 34 kDa |
| GenBank Accession Number | BC001103 |
| Gene Symbol | GULP1 |
| Gene ID (NCBI) | 51454 |
| RRID | AB_10916254 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9UBP9 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for GULP1 antibody 19902-1-AP | Download protocol |
| WB protocol for GULP1 antibody 19902-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The GULP1 Polyclonal antibody (Cat# 19902-1-AP) has 4 citations published in Cardiovascular Diabetology, Cell Death & Disease, International Immunopharmacology, and Aging. The associated research fields include diabetic cardiomyopathy and mitochondrial function, urothelial bladder cancer and lymph node metastasis, osteoarthritis and immunogenic cell death, and chronic obstructive pulmonary disease involving pulmonary macrophage dysfunction.
| Species | Application | Title |
|---|---|---|
Cardiovasc Diabetol GULP1 protects against diabetic cardiomyopathy through IKIP/NF-κB-dependent improvement of mitochondrial function.
| ||
Cell Death Dis The APC/C E3 ligase subunit ANAPC11 mediates FOXO3 protein degradation to promote cell proliferation and lymph node metastasis in urothelial bladder cancer | ||
Int Immunopharmacol Calreticulin-driven immunogenic cell death promotes osteoclast differentiation and osteoarthritis progression via the LRP1/Rac1 signaling | ||
Aging (Albany NY) GATA2 downregulation contributes to pro-inflammatory phenotype and defective phagocytosis of pulmonary macrophages in chronic obstructive pulmonary disease |
